T1	Outcomes 162 191	safety in HIV-infected women.
T2	Outcomes 232 256	safety and acceptability
T3	Outcomes 668 715	severe or life-threatening adverse events (AE).
T4	Outcomes 766 779	urogenital AE
T5	Outcomes 882 894	mild events.
T6	Outcomes 937 950	urogenital AE
T7	Outcomes 1035 1058	intermenstrual bleeding
T8	Outcomes 1190 1192	AE
T9	Outcomes 1258 1279	abdominal/pelvic pain
T10	Outcomes 1480 1515	safe, well tolerated and acceptable
T11	Outcomes 1641 1674	HIV transmission and acquisition.
